Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 03:32:23 23/09/2026 pm IST			5-day change	1st Jan Change
2,876.50 ^INR	+0.17%		+2.22%	+16.41%

03/08	GSK India first-quarter profit rises on steady vaccine demand	RE
03/08	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,81,714	2,24,319	3,29,173	4,87,432	3,86,822	4,87,296	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	25.97%	-
Enterprise Value (EV)	2,56,351	2,07,663	3,29,173	4,87,432	3,86,822	4,87,296	4,87,296
Change	-	-18.99%	58.51%	48.08%	-20.64%	25.97%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	41.8x	36.3x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.4x	15.5x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.4x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.4x	10.3x
EV / Revenue	0x	0x	0x	0x	0x	11.4x	10.3x
EV / EBITDA	0x	0x	0x	0x	0x	32.8x	28.5x
EV / EBIT	0x	0x	0x	0x	0x	33.2x	28.5x
EV / FCF	0x	0x	0x	0x	0x	40.6x	37x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.46%	2.7%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.03%	1.03%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,876.50	2,876.50
Nbr of stocks (in thousands)	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	1,69,406	-
Announcement Date	16/05/22	17/05/23	17/05/24	13/05/25	13/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	41.75x	-	-	1.03%	508.85Cr
ELI LILLY AND COMPANY	33.27x	12.06x	24.51x	0.59%	1,04300Cr
JOHNSON & JOHNSON	29.94x	6.66x	18.64x	2%	65TCr
ABBVIE INC.	33.54x	7.85x	16.21x	2.59%	47TCr
ROCHE HOLDING AG	19.72x	4.82x	11.95x	2.75%	35TCr
NOVARTIS AG	20.01x	5.21x	12.94x	3.07%	27TCr
ASTRAZENECA PLC	21.55x	4.46x	12.7x	1.98%	26TCr
AMGEN INC.	26.04x	6.76x	12.04x	2.46%	22TCr
GILEAD SCIENCES, INC.	-46.18x	6.71x	26.22x	2.16%	19TCr
NOVO NORDISK A/S	11.59x	4.21x	8.76x	4.34%	18TCr
Average	19.12x	6.53x	16.00x	2.29%	36.38TCr
Weighted average by Cap.	23.96x	7.81x	18.02x	1.97%